Date: February 25 - 26, 2016
Location: Vienna, Austria
This innovative B2B event will enable the participants to learn about protein modeling development and engineering advances, preclinical and clinical improvements, current ADC linker chemistry- better linker design for future generations, improving preclinical and clinical translation and creating strong and scalable processes.
Date: Friday, February 26, 2016
Time: 10:20 am
Title: "Site-Specific ADC Generation Using SMARTag™ Technology"
- Enabling precise & programmable site-specific chemical protein modification against a number of different antigens/targets
- Novel conjugation chemistry for ADCs with enhanced stability & increased DAR
- Linker chemistry that optimizes the potency of the cytotoxic payload
Speaker: David Rabuka, Global Head of R&D, Chemical Biology Catalent Pharma Solutions
T (03) 3470-2311
F (03) 3408-5554